Clinical Trial Update: MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating MK0653C in high cardiovascular risk patients with high cholesterol has completed; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• MK0653C

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2014-02-12